MSCI [MSCI] vs CME [CME] Detailed Stock Comparison

MSCI Inc.

NYSE
Loading...

CME Group Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: MSCI Inc. wins in 6 metrics, CME Group Inc. wins in 14 metrics, with 0 ties. CME Group Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric MSCI Inc. CME Group Inc. Better
P/E Ratio (TTM) 34.73 24.34 CME Group Inc.
Price-to-Book Ratio -15.80 3.57 CME Group Inc.
Debt-to-Equity Ratio -2.37 12.86 CME Group Inc.
PEG Ratio 0.71 1.03 MSCI Inc.
EV/EBITDA 26.57 21.55 CME Group Inc.
Profit Margin (TTM) 40.74% 63.31% CME Group Inc.
Operating Margin (TTM) 53.70% 69.66% CME Group Inc.
EBITDA Margin (TTM) 53.70% 69.66% CME Group Inc.
Return on Equity -45.29% 15.92% CME Group Inc.
Return on Assets (TTM) 20.55% 1.55% MSCI Inc.
Free Cash Flow (TTM) $1.46B $4.19B CME Group Inc.
Dividend Yield 1.42% 4.11% CME Group Inc.
1-Year Return 11.94% -5.35% MSCI Inc.
Price-to-Sales Ratio (TTM) 13.72 15.36 MSCI Inc.
Enterprise Value $50.46B $103.28B CME Group Inc.
EV/Revenue Ratio 15.58 15.31 CME Group Inc.
Gross Profit Margin (TTM) 83.33% N/A N/A
Revenue per Share (TTM) $43 $19 MSCI Inc.
Earnings per Share (Diluted) $17.51 $11.73 MSCI Inc.
Beta (Stock Volatility) 1.29 0.30 CME Group Inc.
Short % of Float 1.96% 1.44% CME Group Inc.

MSCI Inc. vs CME Group Inc. Stock Performance Analysis

Loading Price Chart...

MSCI
CME

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
MSCI Inc.0.86%1.68%5.38%8.48%12.47%8.55%
CME Group Inc.1.35%-9.48%-12.97%-22.30%-7.91%-6.32%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
MSCI Inc.11.94%31.88%35.38%718.80%1,628.39%2,429.57%
CME Group Inc.-5.35%47.62%25.26%182.55%402.74%200.07%

Performance & Financial Health Analysis: MSCI Inc. vs CME Group Inc.

MetricMSCICME
Market Information
Market Cap i$43.73B$103.42B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i642,7142,489,654
90 Day Avg. Volume i547,9812,270,221
Last Close$618.87$256.06
52 Week Range$501.08 - $644.68$244.56 - $329.16
% from 52W High-4.00%-22.21%
All-Time High$679.85 (Nov 15, 2021)$329.16 (Mar 03, 2026)
% from All-Time High-8.97%-22.21%
Growth Metrics
Quarterly Revenue Growth0.14%0.15%
Quarterly Earnings Growth0.41%0.21%
Financial Health
Profit Margin (TTM) i0.41%0.63%
Operating Margin (TTM) i0.54%0.70%
Return on Equity (TTM) i-0.45%0.16%
Debt to Equity (MRQ) i-2.3712.86
Cash & Liquidity
Book Value per Share (MRQ)$-38.05$80.03
Cash per Share (MRQ)$5.24$7.56
Operating Cash Flow (TTM) i$1.59B$4.54B
Levered Free Cash Flow (TTM) i$1.21B$4.11B
Dividends
Last 12-Month Dividend Yield i1.42%4.11%
Last 12-Month Dividend i$7.45$12.45

Valuation & Enterprise Metrics Analysis: MSCI Inc. vs CME Group Inc.

MetricMSCI (Apr 24, 2026)CME (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i34.7324.34
Forward P/E i27.1122.14
PEG Ratio i0.711.03
Price to Sales (TTM) i13.7215.36
Price to Book (MRQ) i-15.803.57
Market Capitalization
Market Capitalization i$43.73B$103.42B
Enterprise Value i$50.46B$103.28B
Enterprise Value Metrics
Enterprise to Revenue i15.5815.31
Enterprise to EBITDA i26.5721.55
Risk & Other Metrics
Beta i1.290.30
Book Value per Share (MRQ) i$-38.05$80.03

Financial Statements Comparison: MSCI Inc. vs CME Group Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricMSCI (2025)CME (2025)
Revenue/Sales i3.13B6.52B
Cost of Goods Sold i550.37M907.00M
COGS % of Revenue i17.6%13.9%
Gross Profit i2.58B5.61B
Gross Margin i82.4%86.1%
Research & Development i177.60MN/A
Operating Income (EBIT) i1.71B4.23B
Operating Margin i54.7%64.9%
EBITDA i1.92B98.30M
EBITDA Margin i61.3%1.5%
Pre-Tax Income i1.49B5.33B
Pre-Tax Income % of Revenue i47.7%81.7%
Income Tax i291.95M1.26B
Income Tax % of Revenue i9.3%19.3%
Net Income (Profit) i1.20B4.07B
Profit Margin i38.4%62.5%

Balance Sheet & Liquidity Metrics

MetricMSCI (2025)CME (2025)
Cash & Equivalents i511.67M4.42B
Total Current Assets i1.64B165.36B
Total Current Assets % of Revenue i52.5%2,536.0%
Total Current Liabilities i1.83B160.30B
Total Current Liabilities % of Revenue i58.4%2,458.3%
Long-Term Debt i6.31B3.42B
Long-Term Debt % of Revenue i201.3%52.5%
Total Shareholders Equity i-2.65B28.73B
Retained Earnings i5.43B6.43B
Retained Earnings % of Revenue i173.2%98.7%
Property, Plant & Equipment i112.87M0

Cash Flow Statement Comparison

MetricMSCI (2025)CME (2025)
Operating Cash Flow i1.49B4.54B
Operating Cash Flow % of Revenue i47.7%69.6%
Capital Expenditures iN/A-83.50M
Free Cash Flow i1.46B4.19B
FCF Margin i46.5%64.3%
Debt Repayment i-1.10B-750.00M
Common Stock Repurchase i-2.48B-266.10M

Short Interest & Institutional Ownership Analysis

MetricMSCICME
Shares Short i1.19M4.70M
Short Ratio i2.172.28
Short % of Float i1.96%1.44%
Shares Outstanding i72.90M362.80M
Float Shares i68.75M357.72M
% Held by Insiders i3.60%0.48%
% Held by Institutions i95.27%91.89%
% Held by Public i1.13%7.63%

Dividend Analysis & Yield Comparison: MSCI Inc. vs CME Group Inc.

MetricMSCICME
Last 12-Month Dividend i$7.45$12.45
Last 12-Month Dividend Yield i1.42%4.11%
3-Year Avg Annual Dividend i$6.60$10.83
3-Year Avg Dividend Yield i0.30%0.92%
3-Year Total Dividends i$19.79$32.50
Ex-Dividend DateFeb 13, 2026Mar 10, 2026